EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

High Endothelial Venules in Small Cell Lung Cancer: Prognostic Subtypes and Therapeutic Implications for Immunoradiotherapy

Jiatian Fang iD, Zilian Wang, Hui Wang, Jianxin Xue, Kai Kang

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Jiatian Fang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms, Radioimmunotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: "Qimingxing" Research Fund for Young Talents of West China Hospital, Sichuan University, Natural Science Foundation of Sichuan Province, Postdoctor Research Fund of West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine malignancy with an immunosuppressive tumor microenvironment, and current immunotherapy provides limited benefit. This highlights the need to identify microenvironmental features enabling effective immune responses. High endothelial venules (HEVs) are critical for lymphocyte recruitment and antitumor immunity, yet their roles in SCLC remain poorly understood. To investigate HEV‐related features among SCLC patients, five bulk RNA‐seq datasets comprising 583 tumor samples were integrated. HEV‐related signatures stratified SCLC patients into two subtypes, C1 and C2, associated with HEV‐high and HEV‐low states, respectively. C1 showed a more immune‐active microenvironment and superior prognosis. Consistently, using single‐cell RNA‐seq data and validating the findings by immunofluorescence staining in an independent cohort of 80 patients with SCLC, we confirmed that the presence of HEV structures was associated with a favorable prognosis. We further established a prognostic model and identified five genes, PDCD1 , CXCL9 , ITK , ITGAL , and SH2D1A , as key favorable prognostic factors. A nomogram incorporating age, tumor stage, and the prognostic model was also developed and exhibited satisfactory performance. Additionally, we explored the translational potential of promoting HEV formation as a therapeutic strategy in SCLC. In murine SCLC models, radiotherapy combined with immunotherapy promoted HEV formation and enhanced antitumor efficacy. HEVs appeared to serve as a critical link underlying the therapeutic synergy between radiotherapy and immunotherapy. Collectively, these findings highlight the biological and clinical relevance of HEVs in SCLC and suggest that combination strategies aimed at promoting HEV formation may help overcome the limited efficacy of immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Small Cell Lung CarcinomaLung NeoplasmsRadioimmunotherapyHumansAnimalsPrognosisMiceVenulesTumor MicroenvironmentFemaleMale

Stichwörter der Autor:innen

high endothelial venulesimmunotherapyradiotherapysmall cell lung cancer

Autor:innen und Institutionen

  • Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • West China School of Medicine, West China Hospital, Sichuan University, Chengdu, China.
  • Laboratory of Clinical Cell Therapy, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Jiatian Fang

Förderung

  • "Qimingxing" Research Fund for Young Talents of West China Hospital, Sichuan University
  • Natural Science Foundation of Sichuan Province
  • Postdoctor Research Fund of West China Hospital, Sichuan University
  • National Natural Science Foundation of China

Zitieren

APA

Fang, J., Wang, Z., Wang, H., Xue, J., & Kang, K. (2026). High Endothelial Venules in Small Cell Lung Cancer: Prognostic Subtypes and Therapeutic Implications for Immunoradiotherapy. International Journal of Cancer. https://doi.org/10.1002/ijc.70639

Vancouver

Fang J, Wang Z, Wang H, Xue J, Kang K. High Endothelial Venules in Small Cell Lung Cancer: Prognostic Subtypes and Therapeutic Implications for Immunoradiotherapy. International Journal of Cancer. 2026. doi:10.1002/ijc.70639

BibTeX
@article{Fang2026,
  author = {Fang, Jiatian and Wang, Zilian and Wang, Hui and Xue, Jianxin and Kang, Kai},
  title = {High Endothelial Venules in Small Cell Lung Cancer: Prognostic Subtypes and Therapeutic Implications for Immunoradiotherapy},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70639}
}
Kostenlos starten →